Price Analysis and Forecast
Based on the current market data and technical analysis, here's the price prediction for ResMed (RMD) in 2025:
RMD is expected to trade around $265-275 by end of 2025. This projection is supported by the company's strong fundamentals in sleep and respiratory care segment, which accounts for over 52% of revenue [Relevant Data], combined with positive analyst sentiment. Recent analyst coverage from KeyBanc maintains a Buy rating with a $280 price target.
Key Drivers Supporting This Target:
- Strong market position in sleep apnea devices market
- Consistent revenue growth with Q4 2024 revenue reaching $1.28 billion
- Positive analyst ratings from major firms including Bank of America Securities and KeyBanc
However, recent insider selling activity suggests some caution, with CEO Michael Farrell and other executives selling shares in late 2024. The stock has been trading in a defined range between $228.80 support and $258 resistance levels.
Technical Support Levels:
- Strong support: $228.80
- Secondary support: $230.83
- Current pivot point: $239.01
- Key resistance: $244.06